Show simple item record

dc.contributor.authorGangopadhyay, Aparna
dc.date.accessioned2022-06-02T20:10:33Z
dc.date.accessioned2023-05-11T17:22:20Z
dc.date.available2022-06-02T20:10:33Z
dc.date.available2023-05-11T17:22:20Z
dc.date.created2022-02-07
dc.identifierhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023303spa
dc.identifier.issn1754-6605spa
dc.identifier.urihttps://hdl.handle.net/20.500.12032/107520
dc.description.abstractThe World Health Organization has called for elimination of cervical cancer as a public health problem and has adopted strategies in this regard. However, the estimates for achieving the goals depend on the ability to provide timely treatment in a certain pro- portion of cases. The coronavirus disease 2019 pandemic has had a serious impact on healthcare delivery in many low and middle income countries (LMICs) with the highest burden of cervical cancer; funds and infrastructure are being reallocated to deal with the emergency, and cancer care has been seriously affected. In the absence of clear and reliable estimates, the exact extent of disruption remains unclear. It is, therefore, essen- tial that pragmatic approaches are adopted to save lives. There has been considerable debate regarding the use of the 9 Gy × 2 fractions high dose rate brachytherapy sched- ule for the treatment of locally advanced cervical carcinoma. However, in LMICs with the highest global burden of locally advanced cervical cancer cases, radiation facilities have been using this fractionation schedule in many cases to deal with the overwhelming number of patients, who would have otherwise been denied timely treatment. In view of the current pandemic, and the difficulties in accessing and delivering timely healthcare, mortality owing to delayed treatment cannot be denied in LMICs, which already have underequipped healthcare facilities. Use of the shortest available fractionation schedule to provide timely treatment would serve to save more lives in regions with high incidence and mortality from the disease.spa
dc.formatPDFspa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.subjectBrachytherapyspa
dc.subjectCervix uterispa
dc.subjectCOVID-19 pandemicspa
dc.subjectRadiation dose fractionationspa
dc.titleElimination of cervical cancer as a public health problem - how shorter brachytherapy could make a difference during COVID-19spa


Files in this item

FilesSizeFormatView
36.pdf265.7Kbapplication/pdfView/Open

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by-nc/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc/4.0/

© AUSJAL 2022

Asociación de Universidades Confiadas a la Compañía de Jesús en América Latina, AUSJAL
Av. Santa Teresa de Jesús Edif. Cerpe, Piso 2, Oficina AUSJAL Urb.
La Castellana, Chacao (1060) Caracas - Venezuela
Tel/Fax (+58-212)-266-13-41 /(+58-212)-266-85-62

Nuestras redes sociales

facebook Facebook

twitter Twitter

youtube Youtube

Asociaciones Jesuitas en el mundo
Ausjal en el mundo AJCU AUSJAL JESAM JCEP JCS JCAP